QA: Royalty Pharma plc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001802768_2021_Royalty_Pharma_plc.pdf

Logs

Graph

Absolute values for 0001802768, Royalty Pharma plc

  xvar xval
0 AssetsCurrent 2,696,898,000
1 IntangibleAssetsNetIncludingGoodwill 28,666,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 13,294,722,000
4 LiabilitiesCurrent 307,887,000
5 LiabilitiesNoncurrent 5,816,584,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 181,715,000
9 ResearchAndDevelopmentExpense 26,289,000
10 remainder_Expenses 318,950,000
11 remainder_Revenues 2,122,353,000
12 remainder_NetIncome 106,555,000
13 remainder_ComprehensiveNetIncome -673,152,000
  yvar yval
0 Assets 16,020,286,000
1 Liabilities 6,124,471,000
2 Expenses 526,954,000
3 Revenues 2,122,353,000
4 StockholdersEquity 9,895,815,000
5 NetIncome 1,701,954,000
6 ComprehensiveNetIncome 1,365,378,000
7 BaseVar 12,786,885,500
8 EconomicCapitalRatio 1.66

Edgar->Model Mapping

Feature Distribution

Change over Time